IL141899A0 - Pharmaceutical compositions comprising a chemokine receptor antagonist and a cyclosporin - Google Patents

Pharmaceutical compositions comprising a chemokine receptor antagonist and a cyclosporin

Info

Publication number
IL141899A0
IL141899A0 IL141899??A IL14189999A IL141899A0 IL 141899 A0 IL141899 A0 IL 141899A0 IL 14189999 A IL14189999 A IL 14189999A IL 141899 A0 IL141899 A0 IL 141899A0
Authority
IL
Israel
Prior art keywords
cyclosporin
pharmaceutical compositions
receptor antagonist
chemokine receptor
chemokine
Prior art date
Application number
IL141899??A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL141899A0 publication Critical patent/IL141899A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL141899??A 1998-09-18 1999-09-16 Pharmaceutical compositions comprising a chemokine receptor antagonist and a cyclosporin IL141899A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98117697A EP1000626A1 (en) 1998-09-18 1998-09-18 Chemokine receptor antagonist and cyclosporin in combined therapy
PCT/EP1999/006844 WO2000016796A1 (en) 1998-09-18 1999-09-16 Chemokine receptor antagonist and cyclosporin in combined therapy

Publications (1)

Publication Number Publication Date
IL141899A0 true IL141899A0 (en) 2002-03-10

Family

ID=8232654

Family Applications (2)

Application Number Title Priority Date Filing Date
IL141899??A IL141899A0 (en) 1998-09-18 1999-09-16 Pharmaceutical compositions comprising a chemokine receptor antagonist and a cyclosporin
IL141899A IL141899A (en) 1998-09-18 2001-03-08 Pharmaceutical preparations containing antagonist to the receptor of chemokine, together with cyclosporine

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL141899A IL141899A (en) 1998-09-18 2001-03-08 Pharmaceutical preparations containing antagonist to the receptor of chemokine, together with cyclosporine

Country Status (23)

Country Link
US (1) US6902728B1 (enExample)
EP (2) EP1000626A1 (enExample)
JP (1) JP2003519082A (enExample)
KR (1) KR100613950B1 (enExample)
CN (1) CN1177613C (enExample)
AR (1) AR021810A1 (enExample)
AT (1) ATE227582T1 (enExample)
AU (1) AU766595B2 (enExample)
BR (1) BR9913846A (enExample)
CA (1) CA2344370A1 (enExample)
DE (1) DE69903964T2 (enExample)
DK (1) DK1113811T3 (enExample)
EA (1) EA003181B1 (enExample)
EE (1) EE04705B1 (enExample)
ES (1) ES2186411T3 (enExample)
HK (1) HK1041225B (enExample)
IL (2) IL141899A0 (enExample)
NO (1) NO20011371L (enExample)
PT (1) PT1113811E (enExample)
SI (1) SI1113811T1 (enExample)
UA (1) UA60379C2 (enExample)
WO (1) WO2000016796A1 (enExample)
ZA (1) ZA200101909B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259136B2 (en) 1999-04-30 2007-08-21 Amylin Pharmaceuticals, Inc. Compositions and methods for treating peripheral vascular disease
US6740636B2 (en) * 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection
LT5132B (lt) 2000-07-31 2004-05-25 Schering Aktiengesellschaft Nepeptidiniai ccr1 receptorių antagonistai derinyje su ciklosporinu a širdies transplanto atmetimui gydyti
EP2185719B1 (en) 2007-08-02 2013-11-13 NovImmune SA Anti-rantes antibodies and methods of use thereof
WO2017040515A1 (en) * 2015-08-31 2017-03-09 Hitachi Chemical Co., Ltd. Molecular methods for assessing post kidney transplant complications
JP6624704B2 (ja) 2015-08-31 2019-12-25 日立化成株式会社 尿路上皮疾患の評価のための分子法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU221089B1 (en) * 1994-12-08 2002-08-28 Glaxo Group Ltd Rantes peptide derivates with antagonistic effect and uses thereof
EP0845994A1 (en) * 1995-08-09 1998-06-10 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US6184235B1 (en) * 1996-08-14 2001-02-06 Warner-Lambert Company 2-phenyl benzimidazole derivatives as MCP-1 antagonists
WO1998006751A1 (en) * 1996-08-16 1998-02-19 Research Corporation Technologies, Inc. Mcp-3, rantes and mip-1alpha receptor antagonists

Also Published As

Publication number Publication date
PT1113811E (pt) 2003-03-31
NO20011371D0 (no) 2001-03-16
US6902728B1 (en) 2005-06-07
CA2344370A1 (en) 2000-03-30
EE04705B1 (et) 2006-10-16
AU6191499A (en) 2000-04-10
EA200100366A1 (ru) 2001-08-27
BR9913846A (pt) 2001-06-05
EP1000626A1 (en) 2000-05-17
DE69903964D1 (en) 2002-12-19
SI1113811T1 (en) 2003-04-30
KR100613950B1 (ko) 2006-08-18
EA003181B1 (ru) 2003-02-27
CN1177613C (zh) 2004-12-01
KR20010075060A (ko) 2001-08-09
JP2003519082A (ja) 2003-06-17
EE200100159A (et) 2002-08-15
DK1113811T3 (da) 2003-03-10
ZA200101909B (en) 2001-09-11
ATE227582T1 (de) 2002-11-15
CN1319021A (zh) 2001-10-24
EP1113811B1 (en) 2002-11-13
HK1041225B (zh) 2005-04-22
IL141899A (en) 2007-12-03
NO20011371L (no) 2001-03-16
AU766595B2 (en) 2003-10-16
AR021810A1 (es) 2002-08-07
ES2186411T3 (es) 2003-05-01
UA60379C2 (uk) 2003-10-15
WO2000016796A1 (en) 2000-03-30
DE69903964T2 (de) 2003-03-27
HK1041225A1 (en) 2002-07-05
EP1113811A1 (en) 2001-07-11

Similar Documents

Publication Publication Date Title
HUP0103796A3 (en) Neuropeptide y5 receptor antagonists and medicaments containing them
HUP0102658A3 (en) Pharmaceutical composition containing opioid agonist and antagonist combination
HUP0100626A3 (en) Kappa receptor opioid tetra peptides and pharmaceutical compositions comprising thereof
HUP0302969A3 (en) Npyy5 antagonists, pharmaceutical compositions containing them and their use
IL135797A (en) Thrombin receptor antagonists and pharmaceutical compositions comprising them
EP1000031A4 (en) VITRONECTIN RECEPTOR ANTAGONISTS
HUP9904363A3 (en) Piperidine ether muscarinic antagonists and pharmaceutical compositions containing them
HUP0201372A3 (en) Pharmaceutical compositions comprising cyclosporin
HUP0101411A3 (en) A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof
HUP0302382A3 (en) Il-8 receptor antagonists and pharmaceutical compositions containing them
IL144413A0 (en) Pharmaceutical compositions comprising a tnf antagonist
SI1237559T1 (sl) Farmacevtska kombinacija vsebujoca p2t receptor antagonist in melagatran
IL135189A0 (en) Vitronectin receptor antagonist
IL135188A0 (en) Vitronectin receptor antagonist
IL138576A0 (en) A novel interleukin-1 receptor antagonist and uses thereof
HUP0302003A3 (en) Il-8 receptor antagonists and pharmaceutical compositions containing them
GB9820014D0 (en) Receptor antagonists and uses thereof
GB2363572B (en) Pharmaceutical composition containing cyclosporin
HUP0500079A3 (en) Chemokine receptor antagonists, their use and pharmaceutical compositions containing them
HUP0002929A3 (en) 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same
HUP0201300A3 (en) Il-8 receptor antagonist imidazoidinylidene-2-imino derivatives and pharmaceutical compositions containing them
EG24025A (en) Vitronectin receptor antagonist
HUP0302614A3 (en) Il-8 receptor antagonists and pharmaceutical compositions containing them
HUP0202710A3 (en) Vitronectin receptor antagonists, pharmaceutical compositions containing them and their use
IL147507A0 (en) T-cell receptor y and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed